Clinical Factors Associated with Longer Hospital Stay Following Ovarian Cancer Surgery
<i>Background</i>: Ovarian cancer (OC) is the leading cause of death from gynecologic malignancy and is treated with a combination of cytoreductive surgery and platinum-based chemotherapy. Extended length of stay (LOS) after surgery can affect patient morbidity, overall costs, and hospit...
Main Authors: | Christopher G. Smith, Daniel L. Davenport, Justin Gorski, Anthony McDowell, Brian T. Burgess, Tricia I. Fredericks, Lauren A. Baldwin, Rachel W. Miller, Christopher P. DeSimone, Charles S. Dietrich, Holly H. Gallion, Edward J. Pavlik, John R. van Nagell, Frederick R. Ueland |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-07-01
|
Series: | Healthcare |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9032/7/3/85 |
Similar Items
-
The role of cytoreduction surgery in advanced ovarian cancer (review)
by: R K Tandelov, et al.
Published: (2018-03-01) -
Extended upper abdominal resections as part of debulking surgery at the time of tertiary cytoreduction for relapsed ovarian cancer; case report and literature review
by: Nicolae Bacalbașa, et al.
Published: (2017-11-01) -
Trends in total shoulder arthroplasty from 2005 to 2018: lower complications rates and shorter lengths of stay despite patients with more comorbidities
by: Elise C. Bixby, MD, et al.
Published: (2020-09-01) -
NEOADJUVANT CHEMOTHERAPY FOR EPITHELIAL OVARIAN CANCER. MODERN METHODS AND PATIENTS SELECTION CRITERIA
by: A. E. Solopova, et al.
Published: (2016-09-01) -
Nadir CA-125 serum levels during neoadjuvant chemotherapy and no residual tumor at interval debulking surgery predict prognosis in advanced stage ovarian cancer
by: Kazuto Nakamura, et al.
Published: (2020-08-01)